373 related articles for article (PubMed ID: 28821630)
1. IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis.
Cipolla E; Fisher AJ; Gu H; Mickler EA; Agarwal M; Wilke CA; Kim KK; Moore BB; Vittal R
FASEB J; 2017 Dec; 31(12):5543-5556. PubMed ID: 28821630
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Decay Accelerating Factor Mitigates Fibrotic Responses to Lung Injury.
Vittal R; Fisher AJ; Thompson EL; Cipolla EM; Gu H; Mickler EA; Varre A; Agarwal M; Kim KK; Vasko MR; Moore BB; Lama VN
Am J Respir Cell Mol Biol; 2022 Oct; 67(4):459-470. PubMed ID: 35895592
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis.
Gu H; Mickler EA; Cummings OW; Sandusky GE; Weber DJ; Gracon A; Woodruff T; Wilkes DS; Vittal R
FASEB J; 2014 Oct; 28(10):4223-34. PubMed ID: 24958208
[TBL] [Abstract][Full Text] [Related]
5. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
6. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.
François A; Gombault A; Villeret B; Alsaleh G; Fanny M; Gasse P; Adam SM; Crestani B; Sibilia J; Schneider P; Bahram S; Quesniaux V; Ryffel B; Wachsmann D; Gottenberg JE; Couillin I
J Autoimmun; 2015 Jan; 56():1-11. PubMed ID: 25441030
[TBL] [Abstract][Full Text] [Related]
7. [Blocking IL-17A protects against lung injury-induced pulmonary fibrosis through promoting the activation of p50NF-kappaB].
Mi S; Li Z; Liu H; Hu ZW; Hua F
Yao Xue Xue Bao; 2012 Jun; 47(6):739-44. PubMed ID: 22919721
[TBL] [Abstract][Full Text] [Related]
8. IL-22 inhibits bleomycin-induced pulmonary fibrosis in association with inhibition of IL-17A in mice.
Qu Z; Dou W; Zhang K; Duan L; Zhou D; Yin S
Arthritis Res Ther; 2022 Dec; 24(1):280. PubMed ID: 36564791
[TBL] [Abstract][Full Text] [Related]
9. Potential Mechanisms Underlying TGF-β-mediated Complement Activation in Lung Fibrosis.
Fisher AJ; Cipolla E; Varre A; Gu H; Mickler EA; Vittal R
Cell Mol Med Open Access; 2017; 3(3):. PubMed ID: 29377033
[TBL] [Abstract][Full Text] [Related]
10. Curcumin down-regulates IL-17A mediated p53-fibrinolytic system in bleomycin induced acute lung injury in vivo.
Gouda MM; Bhandary YP
J Cell Biochem; 2018 Sep; 119(9):7285-7299. PubMed ID: 29775223
[TBL] [Abstract][Full Text] [Related]
11. IL-17A promotes lung fibrosis through impairing mitochondrial homeostasis in type II alveolar epithelial cells.
Xiao H; Peng L; Jiang D; Liu Y; Zhu L; Li Z; Geng J; Xie B; Huang X; Wang J; Dai H; Wang C
J Cell Mol Med; 2022 Nov; 26(22):5728-5741. PubMed ID: 36308405
[TBL] [Abstract][Full Text] [Related]
12. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms.
Mi S; Li Z; Yang HZ; Liu H; Wang JP; Ma YG; Wang XX; Liu HZ; Sun W; Hu ZW
J Immunol; 2011 Sep; 187(6):3003-14. PubMed ID: 21841134
[TBL] [Abstract][Full Text] [Related]
13. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.
Wilson MS; Madala SK; Ramalingam TR; Gochuico BR; Rosas IO; Cheever AW; Wynn TA
J Exp Med; 2010 Mar; 207(3):535-52. PubMed ID: 20176803
[TBL] [Abstract][Full Text] [Related]
14. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
[TBL] [Abstract][Full Text] [Related]
15. Generation of bleomycin-induced lung fibrosis is independent of IL-16.
Glass WG; Argentieri RL; Bracht M; Farrell FX; Das AM; Del Vecchio AM; Hogaboam CM; Murray LA
Cytokine; 2009 Apr; 46(1):17-23. PubMed ID: 19232499
[TBL] [Abstract][Full Text] [Related]
16. Curcumin alleviates IL-17A-mediated p53-PAI-1 expression in bleomycin-induced alveolar basal epithelial cells.
Gouda MM; Prabhu A; Bhandary YP
J Cell Biochem; 2018 Feb; 119(2):2222-2230. PubMed ID: 28902433
[TBL] [Abstract][Full Text] [Related]
17. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
[TBL] [Abstract][Full Text] [Related]
18. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis.
Gasse P; Riteau N; Vacher R; Michel ML; Fautrel A; di Padova F; Fick L; Charron S; Lagente V; Eberl G; Le Bert M; Quesniaux VF; Huaux F; Leite-de-Moraes M; Ryffel B; Couillin I
PLoS One; 2011; 6(8):e23185. PubMed ID: 21858022
[TBL] [Abstract][Full Text] [Related]
19. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice.
Li X; Rayford H; Uhal BD
Am J Pathol; 2003 Dec; 163(6):2523-30. PubMed ID: 14633624
[TBL] [Abstract][Full Text] [Related]
20. WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis.
Aumiller V; Balsara N; Wilhelm J; Günther A; Königshoff M
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):96-104. PubMed ID: 23526221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
